Legacy Wealth Asset Management, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1846151 WOODBURY, MN

Position in HALO

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$294,530

+$47,191 QoQ

Shares Held

3,763

-1.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#25

of 50 holders

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Legacy Wealth Asset Management, LLC holds $4,063,533 across 4 Biotechnology names. HALO ranks #3 (7.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GMAB	Genmab A/S	102,164	$2,806,445
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,496	$743,108
3	HALO	Halozyme Therapeutics, Inc. This page	3,763	$294,530
4	ALNY	Alnylam Pharmaceuticals, Inc.	729	$219,450

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$294,530	3,763	-1.7%	Shares	Sole	2026-07-09
2026-03-31	$247,339	3,827	+3.7%	Shares	Sole	2026-04-08
2025-12-31	$248,269	3,689	+1.6%	Shares	Sole	2026-01-12
2025-09-30	$266,224	3,630	-26.7%	Shares	Sole	2025-10-14
2025-06-30	$257,759	4,955	+25.6%	Shares	Sole	2025-07-30
2025-03-31	$251,730	3,945	+2.3%	Shares	Sole	2025-04-09
2024-09-30	$220,831	3,858	—	Shares	Sole	2024-10-23
No filing history on record for this holder in this stock.